Composition : Ticagrelor 60 mg & 90 mg Tablets
Marketing Division: Spectra Healthcare-Rojo
Ticalor belongs to the class of Anti-platelets.
Ticalor is indicated to reduce the risk of:
- CV death, Myocardial Infarction (MI) & Stroke in patients with Acute Coronary Syndrome (ACS) or a history of MI.
- First MI or Stroke in patients with Coronary Artery Disease (CAD) at high risk for such events.
- Stroke in patients with acute ischemic stroke or high-risk Transient Ischemic Attack (TIA).